Sylvester Comprehensive Cancer Center shared a post on LinkedIn:
“Aman Chauhan, an expert on neuroendocrine cancers, and Abdulrahman Sinno, an expert on gynecological cancers, are collaborating with industry partners to conduct an investigator-initiated, phase 1 clinical trial.
The trial explores a novel combination of treatments for patients with gynecological and other neuroendocrine cancers who have not responded to standard cancer therapies.
Gynecological neuroendocrine carcinoma (NEC) is exceptionally rare, leaving patients with extremely limited treatment options.
‘When it’s advanced, most patients don’t survive for more than a year, year-and-a-half,’ said Dr. Chauhan.
As South Florida’s only National Cancer Institute (NCI)-designated cancer center, we’re uniquely equipped to manage NEC cases.
Our expertise is improving outcomes and establishing Sylvester as a national and international referral center for neuroendocrine cancers.
Learn about our innovative approach.”
